On March 13, the FDA approved a new drug that in recent clinical trials, delayed the spread of advanced breast cancer who were no longer showing any reaction to Hereceptin. Hereceptin is a drug which affectively combats cancerous tumors filled with too much HER-2 protein.
The new drug called Tykerb, couple with chemotherapy, has show in clinical trials to do a better job of fighting breast cancer than chemo alone.
Dr. Gary M. Freedman, a radiation oncologist at the Fox Chase Cancer Center in Philadelphia said,”There’s still a lot of questions that remain, but this study confirms that five years of tamoxifen alone is really becoming the wrong answer for most postmenopausal women. At this point, you have to say that aromatase inhibitors are in the mix of treatment at some point.”
But is there a place for the medication in the prevention of new breast cancer cases? That answer still remains elusive so we don’t know if it should be given to healthy women as a way of reducing breast cancer risk.
Tamoxifen must still undergo many tests and trials before it will even be considered for approval. But it is definitely a step in the right direction not to just find a new better cure, but to also realize where our current treatments fall short.
Related posts:
- Definition of Stage IV Breast Cancer by Ray Lam Stage IV breast...
- Breast Cancer Symptoms by Ray Lam In our world...
- Metastatic Breast Cancer by Ray Lam A diagnosis of...
- Breast Cancer Treatment and Side Effects by Ray Lam The diagnosis of...
- Breast Cancer Awareness Day - Your Wake-up Call by Roselyn Capen Breast...
0 Responses to “Breast Cancer Drugs”